10-Q quarterly report · filed May 3, 2018

Teleflex Inc (TFX) Q2 2018 10-Q Quarterly Report

Short answer

Teleflex Inc (TFX) filed its Q2 2018 10-Q quarterly report on May 3, 2018 for the quarter ended Apr 1, 2018.

Teleflex Inc Q2 2018 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $587.2M, up 20.4% YoY from $487.9M, driven by acquisitions and $24.5M favorable currency impact
  • Gross margin 56.4% vs 52.4% YoY; SG&A margin 36.7% vs 33.6%
  • Best segment Interventional North America: revenue $60.2M, up 50.7%; worst Surgical North America: revenue $40.7M, down 11.5%
  • Operating cash flow $86.8M vs $90.9M; capital expenditures $15.7M, acquisition payments $3.7M, debt repayment $18.5M
  • 2018 Footprint plan: $102M-$133M charges, $25M-$30M annual savings at completion; credit and customer-payment risks remain headwinds

Risk Factors

  • No Risk Factors section provided, preventing identification of newly added or materially changed risks since the 2017 10-K
  • Acquisition obligation: NeoTract contingent consideration up to $375 million tied to sales goals through 2020
  • Restructuring execution: 2016 footprint plan expected substantially complete by end of 2018
  • Revenue concentration: Hospitals and healthcare providers represented 87% of quarterly net revenues
  • Financial exposure: Long-term borrowings totaled $2.154 billion at April 1, 2018

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Teleflex Inc quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.